Home
About THA
Affiliates
THA Board of Directors
Affiliates
Delaware THA
Florida THA
Illinois THA
Maryland THA
New Jersey THA
New York THA
Pennsylvania THA
Aftercare
DTHA – CANTER MidAtlantic and MidAtlantic Horse Rescue
ITHA – Galloping Out
MTHA – Beyond The Wire
NJTHA – Second Call
NYTHA – Take2
PTHA – Turning For Home
Thoroughbred Aftercare Alliance
Retired Racehorse Project
Horsemen Resources
Claiming Rules
Condition Books
Continuing Education
Entries
Horsemen’s Accounts
Industry Links
Layoff Report
Licensing
Mid-Atlantic Strategic Plan to Reduce Equine Fatalities
Overnights
Owner Concierge
Racetracks
Racing Commissions
Results
Rules and Regulations
Stall Applications
State Fact Books (JC)
Video Replays
Medication Information
Uniform Medication Overview
Controlled Therapeutic Substances List & Guidelines
Joint Injection Reporting Requirements
THA’s Position on Lasix
Medication Alerts
Multiple Medication Violation Penalty System
National Uniform Medication Progress
Out-of-Competition Testing
Racing Medication and Testing Consortium
ARCI Uniform Classification of Foreign Substances
State Medication Regulations
ARCI Penalty Guidelines
News
Thoroughbred Horsemen's Association
Search for:
Home
About THA
Affiliates
THA Board of Directors
Affiliates
Delaware THA
Florida THA
Illinois THA
Maryland THA
New Jersey THA
New York THA
Pennsylvania THA
Aftercare
DTHA – CANTER MidAtlantic and MidAtlantic Horse Rescue
ITHA – Galloping Out
MTHA – Beyond The Wire
NJTHA – Second Call
NYTHA – Take2
PTHA – Turning For Home
Thoroughbred Aftercare Alliance
Retired Racehorse Project
Horsemen Resources
Claiming Rules
Condition Books
Continuing Education
Entries
Horsemen’s Accounts
Industry Links
Layoff Report
Licensing
Mid-Atlantic Strategic Plan to Reduce Equine Fatalities
Overnights
Owner Concierge
Racetracks
Racing Commissions
Results
Rules and Regulations
Stall Applications
State Fact Books (JC)
Video Replays
Medication Information
Uniform Medication Overview
Controlled Therapeutic Substances List & Guidelines
Joint Injection Reporting Requirements
THA’s Position on Lasix
Medication Alerts
Multiple Medication Violation Penalty System
National Uniform Medication Progress
Out-of-Competition Testing
Racing Medication and Testing Consortium
ARCI Uniform Classification of Foreign Substances
State Medication Regulations
ARCI Penalty Guidelines
News
Author Archives: Tom LaMarra
RTMC revises withdrawal guidance for phenylbutazone
HIWU lists racetracks, laboratories participating in AMDC Program launch
Pennsylvania commission votes to enter nine-month agreements with HISA
RMTC issues critical withdrawal guidance for Controlled Therapeutic Substances
Equine Injury Database: Fatality rate in racing falls to 1.25 per 1,000 starts
Both houses of NY legislature signal support for Belmont Park plan
New PA governor’s proposed budget does not call for shift of PRHDTF revenue
HIWU issues notice on enforcement of regulation on bisphosphonates
Standardbred industry partners with USADA lab on blood-doping research
HISA to begin ‘can’t race’ flagging; clarifies rule on intra-articular injections
PHRC plans special meeting to discuss HISA-related issues
Officials outline HISA Anti-Doping and Medication Control Program
U.S. Sixth Circuit Court of Appeals opinion: HISA is constitutional
Maryland Racing Commission to take role in contract talks
RMTC Committee to develop withdrawal guidance for controlled substances
Fifth Circuit Appeals Court rejects motions from HISA, FTC
FTC republishes HISA Anti-Doping and Medication Control Program rules
Delaware Park to offer 85 racing programs in 2023
←
older
newer
→